Logo image of KRA

Kraton Corporation (KRA) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:KRA - Common Stock

46.49
+0.01 (+0.02%)
Last: 3/14/2022, 8:12:45 PM
46.48
-0.01 (-0.02%)
After Hours: 3/14/2022, 8:12:45 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to KRA. KRA was compared to 82 industry peers in the Chemicals industry. KRA may be in some trouble as it scores bad on both profitability and health. KRA is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year KRA was profitable.
KRA Yearly Net Income VS EBIT VS OCF VS FCFKRA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 0 100M -100M 200M -200M

1.2 Ratios

Industry RankSector Rank
ROA 7.66%
ROE 25.51%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
KRA Yearly ROA, ROE, ROICKRA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 0 20 -20

1.3 Margins

Industry RankSector Rank
OM 12.93%
PM (TTM) 8.45%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
KRA Yearly Profit, Operating, Gross MarginsKRA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 0 10 -10 20

More info and screens

1

2. Health

2.1 Basic Checks

  • KRA has more shares outstanding than it did 1 year ago.
  • KRA has a better debt/assets ratio than last year.
KRA Yearly Shares OutstandingKRA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 10M 20M 30M
KRA Yearly Total Debt VS Total AssetsKRA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • KRA has an Altman-Z score of 2.15. This is not the best score and indicates that KRA is in the grey zone with still only limited risk for bankruptcy at the moment.
  • KRA has a Debt/Equity ratio of 1.03. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF N/A
Altman-Z 2.15
ROIC/WACCN/A
WACCN/A
KRA Yearly LT Debt VS Equity VS FCFKRA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 500M 1B 1.5B

2.3 Liquidity

  • KRA has a Current Ratio of 1.64. This is a normal value and indicates that KRA is financially healthy and should not expect problems in meeting its short term obligations.
  • A Quick Ratio of 0.75 indicates that KRA may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.64
Quick Ratio 0.75
KRA Yearly Current Assets VS Current LiabilitesKRA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 200M 400M 600M 800M

More info and screens

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 121.71% over the past year.
  • The Earnings Per Share has been growing slightly by 4.01% on average over the past years.
  • The Revenue has grown by 54.01% in the past year. This is a very strong growth!
  • KRA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.47% yearly.
EPS 1Y (TTM)121.71%
EPS 3Y-3.17%
EPS 5Y4.01%
EPS Q2Q%347.83%
Revenue 1Y (TTM)54.01%
Revenue growth 3Y-0.69%
Revenue growth 5Y2.47%
Sales Q2Q%25.95%

3.2 Future

  • Based on estimates for the next years, KRA will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.27% on average per year.
  • The Revenue is expected to grow by 1.89% on average over the next years.
EPS Next Y12.54%
EPS Next 2Y9.58%
EPS Next 3Y11.84%
EPS Next 5Y13.27%
Revenue Next Year-0.57%
Revenue Next 2Y2.13%
Revenue Next 3Y1.8%
Revenue Next 5Y1.89%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
KRA Yearly Revenue VS EstimatesKRA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B
KRA Yearly EPS VS EstimatesKRA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

  • KRA is valuated correctly with a Price/Earnings ratio of 16.26.
  • The average S&P500 Price/Earnings ratio is at 27.30. KRA is valued slightly cheaper when compared to this.
  • With a Price/Forward Earnings ratio of 14.44, KRA is valued correctly.
  • When comparing the Price/Forward Earnings ratio of KRA to the average of the S&P500 Index (24.04), we can say KRA is valued slightly cheaper.
Industry RankSector Rank
PE 16.26
Fwd PE 14.44
KRA Price Earnings VS Forward Price EarningsKRA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.15
KRA Per share dataKRA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.3
PEG (5Y)4.06
EPS Next 2Y9.58%
EPS Next 3Y11.84%

More info and screens

0

5. Dividend

5.1 Amount

  • KRA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Kraton Corporation

NYSE:KRA (3/14/2022, 8:12:45 PM)

After market: 46.48 -0.01 (-0.02%)

46.49

+0.01 (+0.02%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)N/A
Earnings (Next)04-26
Inst Owners1.77%
Inst Owner Change0%
Ins Owners11.54%
Ins Owner Change0%
Market Cap1.50B
Revenue(TTM)2.41B
Net Income(TTM)203.43M
Analysts48
Price Target47.43 (2.02%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 16.26
Fwd PE 14.44
P/S 0.62
P/FCF N/A
P/OCF N/A
P/B 1.88
P/tB N/A
EV/EBITDA 5.15
EPS(TTM)2.86
EY6.15%
EPS(NY)3.22
Fwd EY6.92%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS74.7
BVpS24.74
TBVpSN/A
PEG (NY)1.3
PEG (5Y)4.06
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 7.66%
ROE 25.51%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 12.93%
PM (TTM) 8.45%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.91
Health
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.64
Quick Ratio 0.75
Altman-Z 2.15
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)121.71%
EPS 3Y-3.17%
EPS 5Y4.01%
EPS Q2Q%347.83%
EPS Next Y12.54%
EPS Next 2Y9.58%
EPS Next 3Y11.84%
EPS Next 5Y13.27%
Revenue 1Y (TTM)54.01%
Revenue growth 3Y-0.69%
Revenue growth 5Y2.47%
Sales Q2Q%25.95%
Revenue Next Year-0.57%
Revenue Next 2Y2.13%
Revenue Next 3Y1.8%
Revenue Next 5Y1.89%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

Kraton Corporation / KRA FAQ

What is the ChartMill fundamental rating of Kraton Corporation (KRA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to KRA.


Can you provide the valuation status for Kraton Corporation?

ChartMill assigns a valuation rating of 5 / 10 to Kraton Corporation (KRA). This can be considered as Fairly Valued.


What is the profitability of KRA stock?

Kraton Corporation (KRA) has a profitability rating of 6 / 10.


What is the expected EPS growth for Kraton Corporation (KRA) stock?

The Earnings per Share (EPS) of Kraton Corporation (KRA) is expected to grow by 12.54% in the next year.